DL-Sulforaphane

Modify Date: 2024-01-03 03:39:22

DL-Sulforaphane Structure
DL-Sulforaphane structure
Common Name DL-Sulforaphane
CAS Number 4478-93-7 Molecular Weight 177.288
Density 1.2±0.1 g/cm3 Boiling Point 368.2±25.0 °C at 760 mmHg
Molecular Formula C6H11NOS2 Melting Point N/A
MSDS Chinese USA Flash Point 176.5±23.2 °C

 Use of DL-Sulforaphane


Sulforaphane is an isothiocyanate present naturally in widely consumed vegetables; has shown anticancer and cardioprotective activities.

 Names

Name sulforaphane
Synonym More Synonyms

 DL-Sulforaphane Biological Activity

Description Sulforaphane is an isothiocyanate present naturally in widely consumed vegetables; has shown anticancer and cardioprotective activities.
Related Catalog
Target

HDAC

In Vitro Sulforaphane induces a cell cycle arrest in a dose-dependent manner, followed by cell death. This sulforaphane-induced cell cycle arrest was correlated with an increased expression of cyclins A and B1. Sulforaphane induces cell death via an apoptotic process. Sulforaphane inhibits the reinitiation of growth and diminishes cellular viability in quiescent colon carcinoma cells (HT29) and has a lower toxicity on differentiated CaCo2 cells[1]. Pre-treatment of H9c2 rat myoblasts with sulforaphane decreases the apoptotic cell number and the expression of pro-apoptotic proteins (Bax, caspase-3 and cytochrome c), as well as the doxorubicin-induced increase in mitochondrial membrane potential. Furthermore, sulforaphane increases the mRNA and protein expression of heme oxygenase-1, which consequently reduces the levels of reactive oxygen species (ROS, measured using MitoSOX Red reagent) in the mitochondria which are induced by doxorubicin[2].
In Vivo Sulforaphane can block the formation of ammary tumors in Sprague-Dawley rats treated with single doses of 9,10-dimethyl-1,2-benzanthracene. Administration of sulforaphane reduces the incidence, multiplicity, and weights and delays the development of the mammary tumors evoked by a single dose of DMBA in female Sprague-Dawley rats[3].
Cell Assay HT29 cells are seeded at low density (5×104 cells/mL) in 35- or 120-mm diameter Primaria dishes in standard medium containing 5% FCS. One day after seeding, medium is changed, and HT29 cells are treated with sulforaphane (0-30 μM). An equivalent amount of the solvent (ethanol) is added to control cells (0.2% final concentration). Drug effect on cellular viability is evaluated using the MTT assay[1].
Animal Admin Rats: At age 47, 48, 49, 50, and 51 days, each animal receives by gavage either 0.5 mL of Emulphor EL-620 alone or the specified doses (75, 100, or 150 μM daily) of sulforaphane or compound 2, 3, or 4 in 0.5 mL of Emulphor EL-620. On day 50, 3 hr after administration of the vehicle or protector, all rats also receive an intragastric instillation of 8.0 mg of DMBA dissolved in 1.0 mL of sesame oil. This dose of DMBA is selected to produce a substantial tumor incidence, but not one so high as to overwhelm a potential chemoprotective effect. The animals are examined once weekly for the appearance and location of palpable tumors. At age 202 days, i.e., 152 days after carcinogen administration, all animals are euthanized with ether and weighed. The tumors are separated from fat and connective tissue by dissection, weighed, and fixed in buffered 10% formalin. All tumors are identified microscopically by examination of stained sections[3].
References

[1]. Gamet-Payrastre L, et al. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res. 2000 Mar 1;60(5):1426-33.

[2]. Li B, et al. Sulforaphane prevents doxorubicin-induced oxidative stress and cell death in rat H9c2 cells. Int J Mol Med. 2015 Jul;36(1):53-64.

[3]. Zhang Y, et al. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornylisothiocyanates. Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3147-50.

 Chemical & Physical Properties

Density 1.2±0.1 g/cm3
Boiling Point 368.2±25.0 °C at 760 mmHg
Molecular Formula C6H11NOS2
Molecular Weight 177.288
Flash Point 176.5±23.2 °C
Exact Mass 177.028198
PSA 80.73000
LogP 0.23
Vapour Pressure 0.0±0.8 mmHg at 25°C
Index of Refraction 1.567
Storage condition −20°C
Water Solubility DMSO: 40 mg/mL, soluble

 MSDS


SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name: DL-Sulforaphane
REACH No.: A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
CAS-No.: 4478-93-7
Relevant identified uses of the substance or mixture and uses advised against
Identified uses: Laboratory chemicals, Manufacture of substances



SECTION 2: Hazards identification
Classification of the substance or mixture
Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008.
This substance is not classified as dangerous according to Directive 67/548/EEC.
Label elements
This substance is not classified as dangerous according to Directive 67/548/EEC.
Other hazards - none

SECTION 3: Composition/information on ingredients
Substances
Synonyms: 1-Isothiocyanato-4-(methylsulfinyl)-butane
Formula: C6H11NOS2
Molecular Weight: 177,29 g/mol
CAS-No.: 4478-93-7
No components need to be disclosed according to the applicable regulations.

SECTION 4: First aid measures
Description of first aid measures
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration.
In case of skin contact
Wash off with soap and plenty of water.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
no data available

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx), Sulphur oxides
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Avoid breathing vapours, mist or gas.
For personal protection see section 8.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Keep in suitable, closed containers for disposal.
Reference to other sections
For disposal see section 13.

SECTION 7: Handling and storage
Precautions for safe handling
Normal measures for preventive fire protection.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are
opened must be carefully resealed and kept upright to prevent leakage.
Recommended storage temperature: -20 °C
Specific end use(s)
A part from the uses mentioned in section 1.2 no other specific uses are stipulated

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
General industrial hygiene practice.
Personal protective equipment
Eye/face protection
Use equipment for eye protection tested and approved under appropriate government standards
such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
impervious clothing, The type of protective equipment must be selected according to the
concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Respiratory protection not required. For nuisance exposures use type OV/AG (US) or type ABEK
(EU EN 14387) respirator cartridges. Use respirators and components tested and approved under
appropriate government standards such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Do not let product enter drains.

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) AppearanceForm: liquid
b) Odourno data available
c) Odour Thresholdno data available
d) pHno data available
e) Melting point/freezingno data available
point
f) Initial boiling point and no data available
boiling range
g) Flash pointno data available
h) Evapouration rateno data available
i) Flammability (solid, gas) no data available
j) Upper/lowerno data available
flammability or
explosive limits
k) Vapour pressureno data available
l) Vapour densityno data available
m) Relative densityno data available
n) Water solubilityno data available
o) Partition coefficient: n- no data available
octanol/water
p) Auto-ignitionno data available
temperature
q) Decompositionno data available
temperature
r) Viscosityno data available
s) Explosive propertiesno data available
t) Oxidizing propertiesno data available
Other safety information
no data available

SECTION 10: Stability and reactivity
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong acids, Strong bases
Hazardous decomposition products
Other decomposition products - no data available
In the event of fire: see section 5

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitisation
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC:No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

SECTION 12: Ecological information
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
no data available

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contaminated packaging
Dispose of as unused product.

SECTION 14: Transport information
UN number
ADR/RID: -IMDG: -IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA:Not dangerous goods
Transport hazard class(es)
ADR/RID: -IMDG: -IATA: -
Packaging group
ADR/RID: -IMDG: -IATA: -
Environmental hazards
ADR/RID: noIMDG Marine pollutant: noIATA: no
Special precautions for user
no data available

SECTION 15: Regulatory information
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment
For this product a chemical safety assessment was not carried out

SECTION 16: Other information
Further information
Copyright 2013 Co. LLC. License granted to make unlimited paper copies for internal use
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Corporation and its Affiliates shall not be held
liable for any damage resulting from handling or from contact with the above product. See
and/or the reverse side of invoice or packing slip for additional terms and conditions of sale.

 Safety Information

Personal Protective Equipment Eyeshields;Gloves;half-mask respirator (US);multi-purpose combination respirator cartridge (US)
Hazard Codes Xn
Safety Phrases S23-S24/25
RIDADR NONH for all modes of transport
WGK Germany 3
HS Code 2930909090

 Synthetic Route

~99%

DL-Sulforaphane Structure

DL-Sulforaphane

CAS#:4478-93-7

Literature: Papi, Alessio; Orlandi, Marina; Bartolini, Giovanna; Barillari, Jessica; Iori, Renato; Paolini, Moreno; Ferroni, Fiammetta; Fumo, Maria Grazia; Pedulli, Gian Franco; Valgimigli, Luca Journal of Agricultural and Food Chemistry, 2008 , vol. 56, # 3 p. 875 - 883

~83%

DL-Sulforaphane Structure

DL-Sulforaphane

CAS#:4478-93-7

Literature: PharmAgra Labs, Inc. Patent: US2008/176942 A1, 2008 ; Location in patent: Page/Page column 8-9 ;

~79%

DL-Sulforaphane Structure

DL-Sulforaphane

CAS#:4478-93-7

Literature: Auriga International; Dubois, Jacques; Marchal, Alfred; Lacroix, Damien; Cabou, Jérôme Patent: US2013/142739 A1, 2013 ; Location in patent: Paragraph 0129-0147 ;

~%

DL-Sulforaphane Structure

DL-Sulforaphane

CAS#:4478-93-7

Literature: Jean, Daniel; Rabhi, Cherif; Schwaab, Veronique Patent: US2006/135618 A1, 2006 ; Location in patent: Page/Page column 4 ;

~%

DL-Sulforaphane Structure

DL-Sulforaphane

CAS#:4478-93-7

Literature: Moon, Joon-Kwan; Kim, Jun-Ran; Ahn, Young-Joon; Shibamoto, Takayuki Journal of Agricultural and Food Chemistry, 2010 , vol. 58, # 11 p. 6672 - 6677

~%

DL-Sulforaphane Structure

DL-Sulforaphane

CAS#:4478-93-7

Literature: Rajski, Scott R.; Mays, Jared Rae Patent: US2013/116203 A1, 2013 ;

~%

DL-Sulforaphane Structure

DL-Sulforaphane

CAS#:4478-93-7

Literature: Auriga International; Dubois, Jacques; Marchal, Alfred; Lacroix, Damien; Cabou, Jérôme Patent: US2013/142739 A1, 2013 ;

~%

DL-Sulforaphane Structure

DL-Sulforaphane

CAS#:4478-93-7

Literature: Chen, Xin; Li, Zhengyi; Sun, Xiaoqiang; Ma, Hongzhao; Chen, Xiaoxin; Ren, Jie; Hu, Kun Synthesis, 2011 , # 24 art. no. F82411SS, p. 3991 - 3996

~%

DL-Sulforaphane Structure

DL-Sulforaphane

CAS#:4478-93-7

Literature: Papi, Alessio; Orlandi, Marina; Bartolini, Giovanna; Barillari, Jessica; Iori, Renato; Paolini, Moreno; Ferroni, Fiammetta; Fumo, Maria Grazia; Pedulli, Gian Franco; Valgimigli, Luca Journal of Agricultural and Food Chemistry, 2008 , vol. 56, # 3 p. 875 - 883

 Customs

HS Code 2930909090
Summary 2930909090. other organo-sulphur compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

 Articles77

More Articles
Novel Nrf2 activators from microbial transformation products inhibit blood-retinal barrier permeability in rabbits.

Br. J. Pharmacol. 172(5) , 1237-49, (2015)

Nuclear factor erythroid 2-related factor 2 (Nrf2) is a redox-sensitive transcription factor that binds to antioxidant response elements located in the promoter region of genes encoding many antioxida...

Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy.

Int. J. Oncol. 47 , 51-60, (2015)

One of the recently emerging anticancer strategies is the use of natural dietary compounds, such as sulforaphane, a cancer-chemopreventive isothiocyanate found in broccoli. Based on the growing eviden...

A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer.

Invest. New Drugs 33(2) , 480-9, (2015)

Diets high in cruciferous vegetables are associated with lower risk of incidence of prostate cancer, including aggressive forms of this disease. Human intervention studies with cruciferous vegetable-r...

 Synonyms

UNII:41684WL1GL
1-isothiocyanato-4-methylsulfinylbutane
MFCD00198068
1-Isothiocyanato-4-(methylsulfinyl)butane
SULFORAPHANE, (±)-
4-Isothiocyanatobutyl methyl sulfoxide
4-Methylsulfinylbutyl isothiocyanate
1-Isothiocyanato-4-[(R)-methylsulfinyl]butane
4-(Methylsulfinyl)butyl isothiocyanate
1-Isothiocyanato-4-(methylsulfinyl)-butane
Butane, 1-isothiocyanato-4-[(R)-(1R)-methylsulfinyl]-
Butane, 1-isothiocyanato-4-(methylsulfinyl)-
(R)-sulforaphane
DL-Sulforaphane
(R)-1-isothiocyanato-4-(methylsulfinyl)butane
Sulforaphane
(-)-Sulforaphane
L-Sulforaphane
4-isothiocyanatobutyl methyl (R)-sulfoxide
(R)-1-Isothiocyanato-4-(methylsulfinyl)butane,4-Methylsulfinylbutyl isothiocyanate
D,L-Sulforaphane
SCN4SO&1
Sulforafan
Top Suppliers:I want be here





Get all suppliers and price by the below link:

DL-Sulforaphane suppliers


Price: $119/10mM*1mLinDMSO

Reference only. check more DL-Sulforaphane price